Detalhe da pesquisa
1.
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
Br J Cancer
; 130(4): 613-619, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182687
2.
Impact of a one-year supervised physical activity program on long-term cancer-related fatigue and mediating effects of the gut microbiota in metastatic testicular cancer patients: protocol of the prospective multicentre, randomized controlled phase-III STARTER trial.
BMC Cancer
; 24(1): 84, 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225551
3.
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Br J Cancer
; 129(12): 1940-1948, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914801
4.
Synchronous brain metastases as a poor prognosis factor in clear cell renal carcinoma: a strong argument for systematic brain screening.
J Neurooncol
; 153(1): 133-141, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837880
5.
Cryoneurolysis in Patients with Dorsal Neuropathic Pain Secondary to Tumor Invasion.
J Vasc Interv Radiol
; 31(6): 917-924, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32376175
6.
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol
; 20(1): 120-133, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30477937
7.
Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial.
BMC Infect Dis
; 19(1): 308, 2019 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30947693
8.
Compliance to regional recommendations for molecular analyses and management of advanced lung cancer patients.
Future Oncol
; 15(18): 2139-2149, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31185741
9.
Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival.
Br J Cancer
; 116(3): 356-361, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28056463
10.
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial.
Clin Cancer Res
; 30(10): 2111-2120, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502104
11.
Cicaderma® in radiation-related dermatitis of breast cancer: Results from the multicentric randomised phase III CICA-RT.
Clin Transl Radiat Oncol
; 41: 100647, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37441546
12.
Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity score.
Radiother Oncol
; 160: 1-8, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845043
13.
Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
Eur J Cancer
; 150: 108-118, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33895682
14.
Very long-term survivors among patients with metastatic soft tissue sarcoma.
Cancer Med
; 8(4): 1368-1378, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30916474
15.
Response to letter entitled: Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
Eur J Cancer
; 157: 527-528, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34509346